Warren Is Right. Presidents Have The Power To Bypass Congress On Drug Pricing.
But like all of health care, it’s complicated.
An Attack Ad That Claims Michigan Sen. Gary Peters Supports ‘Medicare For All’ Doesn’t Hold Up
This one is a big stretch.
Bloomberg y atención médica: traducir su historial como alcalde a nivel nacional
¿Qué puede decirnos el récord de Michael Bloomberg durante su período como alcalde de Nueva York sobre cómo podría abordar la atención médica desde la Casa Blanca?
Bloomberg On Health Care: Translating His Mayoral Record To The National Stage
Former New York City Mayor Michael Bloomberg uses health care as a key message in his Democratic presidential primary run. Now that he will be taking the stage in the Feb. 19 debate, the message could take on even more prominence.
Trump’s Claim He ‘Saved’ Preexisting Conditions ‘Part Fantasy, Part Delusion’
The claim, which builds on previous statements and campaign messaging, drew strong reactions.
Warren and Klobuchar Say They Can Lower Drug Prices Without Congress’ Help
Democratic presidential candidates also returned to now-familiar themes in debating the differences between “Medicare for All” and more incremental reforms.
Sanders Targets Health Industry Profits. Are His Figures Right?
Calculations are complicated, but correct.
Team Trump Says Administration’s Action On Health Care ‘Is Working.’ Is It?
The impact of the Trump administration’s health policies is not as clear-cut as the president’s reelection campaign suggests.
Demócratas debaten si es “realista” un Medicare para Todos
Los siete candidatos que participaron del último debate de 2019 hablaron sobre la practicidad de una reforma radical de la atención médica, específicamente, de Medicare para Todos.
Yang And Sanders Use Maternal Mortality Stats To Talk About Race
These numbers are stark.
Warren’s Argument That Millions Can’t Afford Their Rx Drugs Holds Up
‘Medication insecurity’ is a thing.
Democrats Debate Whether ‘Medicare For All’ Is ‘Realistic’
Candidates again sparred over “Medicare for All” and other approaches to health reform — but this time they waited more than two hours before wading into health policy issues.
Pharma’s Take On The Pelosi Drug-Pricing Bill: Fair Warning Or Fearmongering?
The pharmaceutical industry’s argument that capping drug prices would compromise drug innovation stands “on very shaky ground.”
Did Joe Biden Overstate Democratic Voters’ Opposition To ‘Medicare For All’?
The term “vast” sets a high bar.
Do 160 Million Americans Really Like Their Health Plans? Kind Of
Former Vice President Joe Biden’s claim during the latest Democratic presidential debate relies on a squishy number, and the context matters.
Surgeon General’s Marijuana Warning Omits Crucial Context
Surgeon General Jerome Adams said the drug has a “unique impact” on the developing brain — technically true, but neglecting a vital comparison to other drugs, as well as shortcomings in the existing research.
Big picture remains hazy, but these numbers add up.
Refereeing Pete Buttigieg, Elizabeth Warren On Public Support For ‘Medicare For All’
Polling supports Buttigieg’s claim.
Warren Trots Out Her Own Harvard Law Research
Warren’s claim on health insurance and bankruptcy is narrow enough to hold up.
Biden Gets Too Specific On ‘Medicare For All’ Tax Hikes
It comes down to questionable methodology.
